Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT03941730 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03941730
Sponsor: Mayo Clinic
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Triple-Negative Breast Carcinoma Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Triple-Negative Breast Carcinoma Recurrent Breast Carcinoma

Start date: 2019-08-28
Primary completion: 2024-07-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.